Work

Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation–Positive Non–Small Cell Lung Cancer

Year: 2016

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-15-2815

Authors: Ferdinandos Skoulidis, Vassiliki A. Papadimitrakopoulou

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2555424095

FWCI: 4.78

Cites: 23

Cited by: 35

Related to: 10